The Big ShiftBy
In recent months, I’ve repeatedly made the point that the financial crisis was a symptom, not a cause. Innovation was weaker than expected, private sector job growth outside of healthcare was virtually nonexistent, while real wages and real stock values showed little gains from the late 1990s to the end of 2007, when the recession supposedly started. Most distressingly, stock prices for the nation’s innovative sectors, biotech/pharma and information technology, showed a sharp plunge in real terms from 1998 to 2007.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Tesla Unveils ‘World’s Fastest Production Car’ and Electric Big Rig
- Norway Idea to Exit Oil Stocks Is ‘Shot Heard Around the World’
- Goldman Sachs Sees Four 2018 Fed Rate Hikes as U.S. Growth Gains
- Honda Recalls 800,000 Odyssey Minivans Linked to Injuries
- The Questionable Math Behind Manafort’s Extravagant Home Renovations